SE451797B - Sett att framstella typ ii interferon - Google Patents

Sett att framstella typ ii interferon

Info

Publication number
SE451797B
SE451797B SE8000243A SE8000243A SE451797B SE 451797 B SE451797 B SE 451797B SE 8000243 A SE8000243 A SE 8000243A SE 8000243 A SE8000243 A SE 8000243A SE 451797 B SE451797 B SE 451797B
Authority
SE
Sweden
Prior art keywords
interferon
cells
human
type
specific type
Prior art date
Application number
SE8000243A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000243L (sv
Inventor
K Sugimoto
S Yuen
Original Assignee
Hayashibara Ken
Ashida Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Ken, Ashida Shin filed Critical Hayashibara Ken
Publication of SE8000243L publication Critical patent/SE8000243L/xx
Publication of SE451797B publication Critical patent/SE451797B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SE8000243A 1979-01-18 1980-01-11 Sett att framstella typ ii interferon SE451797B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP454479A JPS5598118A (en) 1979-01-18 1979-01-18 Preparation of type-2 interferon and drug containing the same

Publications (2)

Publication Number Publication Date
SE8000243L SE8000243L (sv) 1980-07-19
SE451797B true SE451797B (sv) 1987-11-02

Family

ID=11586983

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8000243A SE451797B (sv) 1979-01-18 1980-01-11 Sett att framstella typ ii interferon
SE8701856A SE456741B (sv) 1979-01-18 1987-05-06 Saett att framstaella human-specifikt typ ii-interferon

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8701856A SE456741B (sv) 1979-01-18 1987-05-06 Saett att framstaella human-specifikt typ ii-interferon

Country Status (16)

Country Link
US (1) US4285929A (cs)
JP (1) JPS5598118A (cs)
AU (1) AU536477B2 (cs)
BE (1) BE881217A (cs)
CA (1) CA1135622A (cs)
CH (1) CH650801A5 (cs)
DE (1) DE3001585C2 (cs)
DK (1) DK169479B1 (cs)
ES (1) ES487852A0 (cs)
FI (1) FI68519C (cs)
FR (1) FR2446637A1 (cs)
GB (1) GB2040292B (cs)
IT (1) IT1143056B (cs)
NL (1) NL8000291A (cs)
NO (1) NO156051C (cs)
SE (2) SE451797B (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55154919A (en) * 1979-05-24 1980-12-02 Hayashibara Takeshi Preparation of interferon
US4396601A (en) * 1980-03-26 1983-08-02 The Regents Of The University Of Calif. Gene transfer in intact mammals
US4497796A (en) * 1980-03-26 1985-02-05 The Regents Of The University Of California Gene transfer in intact mammals
JPS5826317B2 (ja) * 1980-12-30 1983-06-02 株式会社 林原生物化学研究所 ヒト甲状腺刺激ホルモンの製造方法
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
JPS5743696A (en) * 1980-08-27 1982-03-11 Hayashibara Biochem Lab Inc Preparation of human luteinizing hormone
JPS585671B2 (ja) * 1980-08-27 1983-02-01 株式会社 林原生物化学研究所 ヒト卵胞刺激ホルモンの製造方法
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
JPS6030657B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒト細胞増殖促進因子の製造方法
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
US5096705A (en) * 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
JPS58126786A (ja) * 1982-01-25 1983-07-28 Hayashibara Biochem Lab Inc ヒトカリクレインの製造方法
US4624917A (en) * 1982-02-17 1986-11-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human T-cell growth factor
FR2523155B1 (fr) * 1982-03-11 1987-10-16 Hayashibara Biochem Lab Preparation de facteur de croissance des cellules t humaines
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
US4683199A (en) * 1983-01-31 1987-07-28 Sloan-Kettering Institute For Cancer Research Interleukin-2 dependent cytotoxic T-cell clones
US4599306A (en) * 1983-04-15 1986-07-08 Amgen Monoclonal antibodies which specifically bind to human immune interferon
US4723000A (en) * 1983-07-05 1988-02-02 Biospectrum, Inc. Human interferon gamma and interleukin-2
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
JPS60155137A (ja) * 1984-01-23 1985-08-15 Takeda Chem Ind Ltd 高濃度ヒトγ型インタ−フエロン水溶液の製造法
DE3521733A1 (de) * 1985-06-18 1986-12-18 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung
DE3436637A1 (de) * 1984-10-05 1986-04-10 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
DE3436638C2 (de) * 1984-10-05 1992-10-08 Bioferon biochemische Substanzen GmbH & Co, 7958 Laupheim Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPS61137828A (ja) * 1984-12-07 1986-06-25 Shionogi & Co Ltd γ−インタ−フエロン製剤組成物
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
WO1992017209A1 (en) * 1991-04-08 1992-10-15 Sumitomo Pharmaceuticals Company, Limited Porous solid preparation containing physiologically active protein substance
US6514728B1 (en) * 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
BR112014026360A2 (pt) 2012-04-23 2017-06-27 Gen Electric aerofólio de turbina e pá de turbina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6914761D0 (pt) * 1969-01-17 1973-03-08 Merck & Co Inc Processos quimicos
JPS5134442B2 (cs) * 1972-05-04 1976-09-27
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5654158A (en) * 1979-10-09 1981-05-14 Hitachi Ltd Control system for call waiting

Also Published As

Publication number Publication date
FR2446637B1 (cs) 1983-07-18
ES8103162A1 (es) 1981-02-16
SE456741B (sv) 1988-10-31
ES487852A0 (es) 1981-02-16
IT8047632A0 (it) 1980-01-17
IT1143056B (it) 1986-10-22
DE3001585A1 (de) 1980-07-31
US4285929A (en) 1981-08-25
CA1135622A (en) 1982-11-16
SE8701856D0 (sv) 1987-05-06
FR2446637A1 (fr) 1980-08-14
AU5456180A (en) 1980-07-24
FI800147A (fi) 1980-07-19
JPS631296B2 (cs) 1988-01-12
SE8000243L (sv) 1980-07-19
AU536477B2 (en) 1984-05-10
CH650801A5 (fr) 1985-08-15
NO156051B (no) 1987-04-06
FI68519B (fi) 1985-06-28
GB2040292A (en) 1980-08-28
DK169479B1 (da) 1994-11-07
NO800105L (no) 1980-07-21
FI68519C (fi) 1985-10-10
GB2040292B (en) 1983-04-13
BE881217A (fr) 1980-07-17
NO156051C (no) 1987-07-15
JPS5598118A (en) 1980-07-25
DE3001585C2 (de) 1985-05-15
SE8701856L (sv) 1987-05-06
NL8000291A (nl) 1980-07-22
DK11880A (da) 1980-07-19

Similar Documents

Publication Publication Date Title
SE451797B (sv) Sett att framstella typ ii interferon
SE436969B (sv) Sett att framstella humanspecifikt interferon
US5362490A (en) Human myelomonocyte interferon-gamma, and process for preparation and use thereof
KR930000188B1 (ko) 신규 림포카인(lymphokine), 이 림포카인에 특이적인 모노클로날 항체 및 이들의 제조방법
JPS6227048B2 (cs)
Mazuski et al. Direct effects of endotoxin on hepatocytes: Synthesis of a specific secretory protein
CA1295241C (en) Lymphokine and its production and uses
JP2632849B2 (ja) γ―インターフェロンの製造方法
JPH0214039B2 (cs)
JP2926409B2 (ja) 癌転移抑制因子の製造方法
JPS61263929A (ja) 抗タイプ２インターフェロン感受性疾患剤
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
JPS61115026A (ja) 新リンホカイン２の製造方法
JPS5815921A (ja) 抗リンホトキシン感受性疾患剤
JPH0526468B2 (cs)
JPS61115027A (ja) 新リンホカイン２とその製法および用途
JPH0527640B2 (cs)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8000243-9

Format of ref document f/p: F